MaxCyte, Inc.
NASDAQ: MXCT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Maher Masoud
- Employees
- 91
- Headquarters
- Rockville, United States
- IPO year
- 2021
- Market cap
- $127.5M
- Website
- https://www.maxcyte.com
Loading MXCT…
Loading profile data…Frequently asked questions about MXCT
What does MaxCyte, Inc. (MXCT) do?
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as w...
Where does MXCT trade?
MaxCyte, Inc. (MXCT) trades on the NASDAQ.
What sector is MXCT in?
MaxCyte, Inc. (MXCT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MaxCyte, Inc.?
Maher Masoud is the chief executive officer of MaxCyte, Inc. (MXCT).
Where is MaxCyte, Inc. headquartered?
MaxCyte, Inc. is headquartered in United States.
Does MXCT pay a dividend?
MaxCyte, Inc. (MXCT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MXCT go public?
MaxCyte, Inc. (MXCT) completed its initial public offering in 2021.